Related Experiment Videos
Thrombophilia and chronic venous ulceration
A W Bradbury1, R K MacKenzie, P Burns
1University Department of Vascular Surgery, Lincoln House (Research Institute), Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, U.K.
Summary
Thrombophilia (TP), a risk factor for deep venous thrombosis (DVT), is highly prevalent in chronic venous ulceration (CVU) patients. This suggests TP may directly contribute to CVU development, impacting venous disease management.
Area of Science:
- Vascular Medicine
- Hematology
- Dermatology
Background:
- Thrombophilia (TP) is a known risk factor for deep venous thrombosis (DVT).
- Deep venous thrombosis (DVT) is a significant predisposing factor for chronic venous ulceration (CVU).
- The direct relationship between TP and CVU remains under-investigated.
Purpose of the Study:
- To investigate the prevalence and implications of thrombophilia in patients with chronic venous ulceration.
- To explore the potential mechanisms linking thrombophilia to chronic venous ulceration.
- To highlight the need for reconsidering diagnostic and management strategies for venous diseases.
Main Methods:
- Literature review of studies investigating thrombophilia in patients with chronic venous ulceration.
- Analysis of the prevalence of TP in CVU cohorts compared to DVT cohorts.
- Discussion of potential pathophysiological links between TP and CVU.
Main Results:
- The prevalence of thrombophilia in patients with chronic venous ulceration is notably high.
- This prevalence is comparable to that observed in patients with a history of deep venous thrombosis.
- A significant proportion of CVU patients with high TP prevalence lacked clear DVT history or duplex evidence.
Conclusions:
- Thrombophilia may be an independent risk factor for chronic venous ulceration, potentially acting through macro- or micro-vascular thrombosis.
- The findings necessitate a re-evaluation of the diagnostic workup for CVU patients, considering TP screening.
- Improved understanding of the TP-CVU link can inform targeted prevention and management strategies for patients with venous disease.